TuHURA Biosciences

HURANasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$135.644 M

$2.13 +0.71%

Close of 7 Aug 2026

Revenue

$0.00

#3658 by revenue

Earnings

-$31.0M

Loss-making

Shares outstanding

63,578,528

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations — ranked by market cap

All 501 →

#289Unicycive TherapeuticsUNCY$138.9M
#290Connect BiopharmaCNTB$138.8M
#291TuHURA BiosciencesHURA$135.6M
#292EquilliumEQ$133.4M
#293InflaRxIFRX$133.0M

Where these numbers come from

Share counts and financials for TuHURA Biosciences are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.